Titelia

Holdings of Octagon Capital Advisors LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
26 in 3 countries
Top ten
73.2 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Dianthus Therapeutics Inc 1,946,667163.4M $
2COGENT BIOSCIENCES INC 2,350,00090.5M $
3ABIVAX SA 677,00075.4M $
4ALUMIS INC 2,830,70062.4M $
5ArriVent Biopharma Inc 1,971,05445.5M $
6Taysha Gene Therapies Inc 8,859,91139.6M $
7KYMERA THERAPEUTICS INC 425,00035.4M $
8MIRUM PHARMACEUTICALS INC 338,90031.3M $
9BioAge Labs Inc 1,748,00030.6M $
10Centessa Pharmaceuticals PLC 750,00029.8M $
11KalVista Pharmaceuticals Inc 1,450,00029.2M $
12Terns Pharmaceuticals Inc 530,00027.9M $
13OCULAR THERAPEUTIX INC 3,166,60026.8M $
14Palisade Bio Inc 10,276,31718M $
15Trevi Therapeutics Inc 1,485,00017.7M $
16Disc Medicine Inc 270,00017.3M $
17AKTIS ONCOLOGY INC 960,84717.2M $
18Context Therapeutics Inc 5,250,00013.8M $
19Precision BioSciences Inc 2,236,73212.3M $
20DBV Technologies SA 574,20012M $
21Unicycive Therapeutics Inc 1,000,0006.6M $
22BridgeBio Oncology Therapeutics Inc 719,0006.4M $
23Lexeo Therapeutics Inc 1,100,0006.3M $
24Perspective Therapeutics Inc 791,5553.3M $
25Evommune Inc 143,4723.3M $
26Gossamer Bio Inc 7,750,0002.5M $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 85.8 %
  • France 10.6 %
  • United Kingdom 3.6 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States23707.2M $85.79 %
2France287.4M $10.60 %
3United Kingdom129.8M $3.61 %
Cite this page

Titelia. "Holdings of Octagon Capital Advisors LP". https://titelia.com/en/funds/US13F1839435